Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G. Crystal

Showing results (421-430 of 431) with videos related to

Pageof 44
Sort By:
Human Gene Therapy|June 12, 1999
Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121S R Patel, L Y Lee, C A Mack, et al.
Human Gene Therapy|January 1, 1997
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotypeC A Mack, W R Song, H Carpenter, et al.
The Annals of Thoracic Surgery|February 2, 2000
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121L Y Lee, S R Patel, N R Hackett, et al.
Journal of Vascular Surgery|May 12, 1998
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusionC A Mack, C J Magovern, K T Budenbender, et al.
The Journal of Clinical Investigation|November 5, 1999
Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirusB G Harvey, P L Leopold, N R Hackett, et al.
Gene Therapy|July 30, 2005
AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCLD Sondhi, D A Peterson, E L Giannaris, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 1998
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heartC A Mack, S R Patel, E A Schwarz, et al.
Nature Medicine|November 2, 2001
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthD Lyden, K Hattori, S Dias, et al.
Scientific Reports|January 7, 2017
Radioiodinated Capsids Facilitate In Vivo Non-Invasive Tracking of Adeno-Associated Gene Transfer VectorsP Kothari, B P De, B He, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Pageof 44

Showing results (421-430 of 431) with videos related to

Sort By:
Pageof 44
Human Gene Therapy|June 12, 1999
Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121S R Patel, L Y Lee, C A Mack, et al.
Human Gene Therapy|January 1, 1997
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotypeC A Mack, W R Song, H Carpenter, et al.
The Annals of Thoracic Surgery|February 2, 2000
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121L Y Lee, S R Patel, N R Hackett, et al.
Journal of Vascular Surgery|May 12, 1998
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusionC A Mack, C J Magovern, K T Budenbender, et al.
The Journal of Clinical Investigation|November 5, 1999
Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirusB G Harvey, P L Leopold, N R Hackett, et al.
Gene Therapy|July 30, 2005
AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCLD Sondhi, D A Peterson, E L Giannaris, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 1998
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heartC A Mack, S R Patel, E A Schwarz, et al.
Nature Medicine|November 2, 2001
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthD Lyden, K Hattori, S Dias, et al.
Scientific Reports|January 7, 2017
Radioiodinated Capsids Facilitate In Vivo Non-Invasive Tracking of Adeno-Associated Gene Transfer VectorsP Kothari, B P De, B He, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Pageof 44